Table 2.
Univariate and multivariate analysis
| Clinical features | Univariate analysis
|
Multivariate analysis
|
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Gender | 2.159 (0.528–8.832) | 0.284 | ||
| Age | 0.628 (0.385–1.024) | 0.062 | ||
| HBsAg | 3.546 (1.112–11.306) | 0.032 | 3.158 (0.967–10.307) | 0.057 |
| AFP | 2.194 (0.998–2.322) | 0.008 | 1.330 (0.711–2.490) | 0.372 |
| Cirrhosis | 1.115 (0.582–2.136) | 0.742 | ||
| Tumor number | 2.419 (1.440–4.064) | 0.001 | 1.820 (1.038–3.191) | 0.037 |
| Tumor encapsulation | 0.672 (0.386–1.172) | 0.161 | ||
| Vascular invasion | 5.577 (3.116–9.981) | <0.001 | 3.640 (1.891–7.007) | <0.001 |
| Surrounding invasion | 1.708 (0.990–2.944) | 0.054 | ||
| Clinical stage | 1.477 (0.095–2.412) | 0.119 | 1.164 (0.966–2.699) | 0.068 |
| CL-L1 expression | 0.485 (0.286–0.823) | 0.007 | 0.395 (0.224–0.694) | 0.001 |
Abbreviations: AFP, alpha-fetoprotein; Colec10, collectin subfamily member 10; CI, confidence interval; HBsAg, hepatitis B surface antigen; HR, hazard ratio.